Acrivon Therapeutics Inc (ACRV)
Acrivon Therapeutics Market Cap: 264.31M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 264.31M |
May 15, 2024 | 267.09M |
May 14, 2024 | 258.13M |
May 13, 2024 | 261.84M |
May 10, 2024 | 270.79M |
May 09, 2024 | 251.34M |
May 08, 2024 | 254.11M |
May 07, 2024 | 257.50M |
May 06, 2024 | 272.63M |
May 03, 2024 | 296.10M |
May 02, 2024 | 261.21M |
May 01, 2024 | 254.11M |
April 30, 2024 | 280.66M |
April 29, 2024 | 308.76M |
April 26, 2024 | 261.21M |
April 25, 2024 | 261.52M |
April 24, 2024 | 293.32M |
April 23, 2024 | 303.20M |
April 22, 2024 | 293.63M |
April 19, 2024 | 289.89M |
April 18, 2024 | 325.40M |
April 17, 2024 | 319.22M |
April 16, 2024 | 292.36M |
April 15, 2024 | 296.68M |
April 12, 2024 | 308.42M |
Date | Value |
---|---|
April 11, 2024 | 286.81M |
April 10, 2024 | 235.20M |
April 09, 2024 | 217.77M |
April 08, 2024 | 133.79M |
April 05, 2024 | 146.69M |
April 04, 2024 | 151.44M |
April 03, 2024 | 150.77M |
April 02, 2024 | 151.44M |
April 01, 2024 | 164.12M |
March 28, 2024 | 161.85M |
March 27, 2024 | 146.35M |
March 26, 2024 | 143.29M |
March 25, 2024 | 141.48M |
March 22, 2024 | 139.41M |
March 21, 2024 | 142.57M |
March 20, 2024 | 141.67M |
March 19, 2024 | 123.20M |
March 18, 2024 | 127.25M |
March 15, 2024 | 139.41M |
March 14, 2024 | 114.19M |
March 13, 2024 | 118.92M |
March 12, 2024 | 112.39M |
March 11, 2024 | 111.49M |
March 08, 2024 | 111.49M |
March 07, 2024 | 115.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
MyMD Pharmaceuticals Inc | 4.725M |
Vincerx Pharma Inc | 21.26M |
GlycoMimetics Inc | 18.12M |
Immunic Inc | 112.60M |
Skye Bioscience Inc | 343.83M |
Market Cap Related Metrics
Price to Book Value | 2.448 |
Price | 8.56 |
Earnings Yield | -33.76% |